Department of Animal Sciences, Colorado State University, 108B Animal Sciences Building, Fort Collins, CO 80523-1171, USA.
Appl Environ Microbiol. 2011 Apr;77(7):2479-87. doi: 10.1128/AEM.02626-10. Epub 2011 Feb 4.
Listeria monocytogenes contains (i) epidemic clone (EC) strains, which have been linked to the majority of listeriosis outbreaks worldwide and are overrepresented among sporadic cases in the United States, and (ii) strains commonly isolated from ready-to-eat foods that carry a mutation leading to a premature stop codon (PMSC) in inlA, which encodes the key virulence factor internalin A (InlA). Internalin A binds certain isoforms of the cellular receptor E-cadherin to facilitate crossing the intestinal barrier during the initial stages of an L. monocytogenes infection. Juvenile guinea pigs, which express the human isoform of E-cadherin that binds InlA, were intragastrically challenged with a range of doses of (i) an EC strain associated with a listeriosis outbreak or (ii) a strain carrying a PMSC mutation in inlA. Recovery of L. monocytogenes from tissues (i.e., liver, spleen, mesenteric lymph nodes, and ileum) was used to develop strain-specific dose-response curves on the basis of individual and combined organ data. Modeling of individual and combined organ data revealed an approximate 1.2 to 1.3 log(10) increase in the median infectious dose for the strain carrying a PMSC in inlA relative to that for the EC strain. Inclusion of the strain parameter significantly improved the goodness of fit for individual and combined organ models, indicating a significant shift in median infectious dose for guinea pigs challenged with an inlA PMSC strain compared to that for guinea pigs challenged with an EC strain. Results from this work provide evidence that the L. monocytogenes dose-response relationship is strain specific and will provide critical data for enhancement of current risk assessments and development of future risk assessments.
李斯特菌单核细胞增生李斯特氏菌包含 (i) 流行克隆 (EC) 菌株,这些菌株与世界范围内大多数李斯特菌病爆发有关,并且在美国散发病例中过度表达,以及 (ii) 通常从即食食品中分离出来的菌株,这些菌株携带导致 inlA 过早终止密码子 (PMSC) 的突变,inlA 编码关键毒力因子细胞内蛋白 A (InlA)。细胞内蛋白 A 结合细胞受体 E-钙黏蛋白的某些同工型,以促进李斯特菌感染初期穿过肠道屏障。表达与 InlA 结合的人类同工型 E-钙黏蛋白的幼年豚鼠经胃内挑战一系列剂量的 (i) 与李斯特菌病爆发相关的 EC 菌株,或 (ii) 携带 inlA 中 PMSC 突变的菌株。根据个体和联合器官数据,从组织(即肝、脾、肠系膜淋巴结和回肠)中回收李斯特菌单核细胞增生李斯特氏菌,以建立菌株特异性剂量反应曲线。个体和联合器官数据的建模表明,携带 inlA 中 PMSC 的菌株的中位感染剂量相对于 EC 菌株约增加了 1.2 至 1.3 个对数(10)。包括菌株参数显著改善了个体和联合器官模型的拟合优度,表明与 EC 菌株相比,用 inlA PMSC 菌株挑战的豚鼠的中位感染剂量有明显变化。这项工作的结果提供了证据,证明李斯特菌的剂量反应关系是菌株特异性的,并将为增强当前风险评估和开发未来风险评估提供关键数据。